ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683856 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683856; 2) Community: the network communities that were significantly associated with the response to NSC 683856; 3) Molecule: the relationships between components within communities and NSC 683856; 4) MDR: the compounds that were significantly associated with the NSC 683856.

NSC Compound Enrichment Correlation
NSC 606498 Camptothecin Derivative 0.0273093708703115 0.13087222
NSC 610458 Camptothecin Derivative 0.0273093708703115 0.078733747
NSC 619859 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- 0.0273093708703115 -0.2750491
NSC 620277 4-N,N-bis-2'-cyanoethylaminobenzylidene-4-fluoro aniline 0.0273093708703115 -0.24722589
NSC 639174 Camptothecin Derivative 0.0273093708703115 0.21359187
NSC 644621 Null 0.0273093708703115 -0.13783654
NSC 653860 Null 0.0273093708703115 0.25638211
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.0273093708703115 0.058915909
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0273093708703115 0.23272811
NSC 668523 N,N-bis(2-chloropropyl)-N-methylammonium chloride 0.0273093708703115 0.21082404
Total:59  Current:32    [First] [Prev] [Next] [Last]